Team Europe Support Structure (TESS) for Manufacturing and Access to Vaccines, medicines and health technology products in Africa (MAV+)

TESS MAV+
Belgium

Project summary

The Action’s overall objective is contributing to the TEI MAV+ that aims to facilitate equitable access to safe, effective, quality and affordable essential vaccines, medicines and health technologies for all Africans. This objective pursues SDG 3.8 and promotes ultimately universal health coverage (UHC). Its attainment requires reinforcing African pharmaceutical systems and the regional manufacturing capacity.

Code BEL21003
Start date 21 December 2022
End date 31 December 2025
Stage Execution
Donor European Union
Sector 12110 Health policy and administrative management
Budget Not available

General objective

To contribute the TEI MAV+ that aims to facilitate equitable access to safe, effective, quality and affordable essential vaccines, medicines and health technologies for all Africans

Specific objective

A - Enhance TEI MAV+ coordination, technical expertise, progress monitoring and communication.

News

No news

Related links
  • No related links
Related documents
  • No related documents
Export data